Toward More Tailored Dosing Strategies While the panacea of individualised dosing regimens might represent a leap too far in terms of complexity, the opportunity does exist for pharmaceutical companies to implement a more tailored approach when it comes to dosing, arriving at a more delicate balance of drug exposure, bioavailability, efficacy and safety based on the characteristics of certain patient cohorts
If you enjoyed this article, sign up for our free newsletter and never miss a post!
The decision-made in consultation with healthcare providers-is yours
They want freedom from waking up tired
Post-transplant diabetes mellitus (PTDM), affecting 525% of patients within the first year after transplantation, is another challenge [14]
However, visible hair growth results require multiple hair growth cycles